Stock Track | 4DMedical Soars 5.26% Intraday Following EU Regulatory Approval and A$83 Million Capital Raise

Stock Track
Apr 08

4DMedical Limited's stock soared 5.26% during intraday trading on Wednesday, following two significant positive developments for the medical imaging company.

The surge comes after 4DMedical announced that its CT:VQ imaging technology received CE Mark certification for commercial use across the European Union, providing access to one of the world's largest respiratory imaging markets. Additionally, the company recently completed an A$83,000,002 follow-on equity offering at A$5.90 per share.

The dual announcements represent major milestones for 4DMedical, with the regulatory clearance opening new commercial opportunities in Europe while the capital raise provides additional funding to support the company's operations and growth initiatives.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10